| Year |
Citation |
Score |
| 2015 |
Tolboom N, Berendse HW, Leysen JE, Yaqub M, van Berckel BN, Schuit RC, Ponsen MM, Bakker E, Hoetjes NJ, Windhorst AD, Carlsson ML, Lammertsma AA, Carlsson A. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 472-9. PMID 25248987 DOI: 10.1038/Npp.2014.195 |
0.39 |
|
| 2013 |
Jerlhag E, Steensland P, Fredriksson I, Feltmann K, Egecioglu E, Engel J, Steensland P, Fredriksson I, Feltmann K, Holst S, Franck J, Schilstrom B, Carlsson A, Colombo G, Naassila M, et al. S10 * EMERGING DRUGS FOR TREATING ALCOHOL USE DISORDERS: PRECLINICAL EVIDENCE Alcohol and Alcoholism. 48: i11-i12. DOI: 10.1093/Alcalc/Agt075 |
0.544 |
|
| 2012 |
Steensland P, Fredriksson I, Holst S, Feltmann K, Franck J, Schilström B, Carlsson A. The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens. Biological Psychiatry. 72: 823-31. PMID 22817867 DOI: 10.1016/j.biopsych.2012.06.018 |
0.309 |
|
| 2011 |
Carlsson ML, Burstein ES, Kloberg A, Hansson S, Schedwin A, Nilsson M, Rung JP, Carlsson A. I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1511-22. PMID 21874578 DOI: 10.1007/s00702-011-0704-8 |
0.402 |
|
| 2011 |
Burstein ES, Carlsson ML, Owens M, Ma JN, Schiffer HH, Carlsson A, Hacksell U. II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1523-33. PMID 21866391 DOI: 10.1007/s00702-011-0701-y |
0.405 |
|
| 2011 |
Rung JP, Rung E, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 39-45. PMID 21533991 DOI: 10.1007/s00210-011-0641-y |
0.468 |
|
| 2009 |
Carlsson A, Lindqvist M. Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain Pharmacology & Toxicology. 20: 140-144. PMID 14060771 DOI: 10.1111/J.1600-0773.1963.Tb01730.X |
0.313 |
|
| 2009 |
Nyberg P, Almay BGL, Carlsson A, Masters C, Winblad B. Brain monoamine abnormalities in the two types of Creutzfeldt-Jakob disease. Acta Neurologica Scandinavica. 66: 16-24. PMID 6180593 DOI: 10.1111/J.1600-0404.1982.Tb03125.X |
0.316 |
|
| 2009 |
Carlsson A, Henning M, Lindberg P, Martinson P, Trolin G, Waldeck B, Wickberg B. On the Disulfiram-Like Effect of Coprine, the Pharmacologically Active Principle of Coprinus atramentarius Pharmacology & Toxicology. 42: 292-297. PMID 350009 DOI: 10.1111/J.1600-0773.1978.Tb02204.X |
0.303 |
|
| 2009 |
Granérus A, Eriksson T, Magnusson T, Carlsson A. CORRELATION BETWEEN CONCENTRATION OF DOPA IN PLASMA AND THE “ON-OFF” PHENOMENON Acta Neurologica Scandinavica. 69: 47-48. DOI: 10.1111/J.1600-0404.1984.TB02383.X |
0.492 |
|
| 2009 |
Carlsson A. The Search For New Monoaminergic Receptor Agonists Acta Neurologica Scandinavica. 65: 34-39. DOI: 10.1111/J.1600-0404.1982.Tb03375.X |
0.324 |
|
| 2008 |
Carlsson A, Carlsson ML. Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications. Brain Research Reviews. 58: 374-8. PMID 18511124 DOI: 10.1016/j.brainresrev.2007.09.007 |
0.403 |
|
| 2008 |
Rung JP, Rung E, Helgeson L, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 899-908. PMID 18351286 DOI: 10.1007/s00702-008-0038-3 |
0.463 |
|
| 2007 |
Lahti RA, Tamminga CA, Carlsson A. Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D2 receptor function in vitro. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 1143-6. PMID 17612788 DOI: 10.1007/S00702-007-0784-7 |
0.435 |
|
| 2005 |
Rung JP, Carlsson A, Rydén Markinhuhta K, Carlsson ML. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 827-32. PMID 15916843 DOI: 10.1016/j.pnpbp.2005.03.004 |
0.325 |
|
| 2004 |
Nilsson M, Carlsson A, Markinhuhta KR, Sonesson C, Pettersson F, Gullme M, Carlsson ML. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 677-85. PMID 15276693 DOI: 10.1016/j.pnpbp.2004.05.004 |
0.307 |
|
| 2004 |
Carlsson ML, Carlsson A, Nilsson M. Schizophrenia: From dopamine to glutamate and back Current Medicinal Chemistry. 11: 267-277. PMID 14965231 DOI: 10.2174/0929867043456034 |
0.437 |
|
| 2003 |
Grunder G, Carlsson A, Wong DF. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Archives of General Psychiatry. 60: 974-7. PMID 14557141 DOI: 10.1001/archpsyc.60.10.974 |
0.43 |
|
| 2003 |
Waters S, Kullingsjo J, Sonesson C, Carlsson A, Tedroff J, Waters N. Da stabilisers — fourth generation antipsychotic drugs Schizophrenia Research. 60: 119. DOI: 10.1016/S0920-9964(03)80879-4 |
0.309 |
|
| 2002 |
Tamminga CA, Carlsson A. Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis Curr Drug Target Cns Neurol Disord. 1: 141-147. PMID 12769623 DOI: 10.2174/1568007024606195 |
0.342 |
|
| 2001 |
Carlsson A. A half-century of neurotransmitter research: Impact on neurology and psychiatry Bioscience Reports. 21: 691-710. PMID 12166820 DOI: 10.1023/A:1015556204669 |
0.329 |
|
| 2001 |
Nilsson M, Waters S, Waters N, Carlsson A, Carlsson ML. A behavioural pattern analysis of hypoglutamatergic mice - Effects of four different antipsychotic agents Journal of Neural Transmission. 108: 1181-1196. PMID 11725821 DOI: 10.1007/s007020170008 |
0.342 |
|
| 2000 |
Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia Biological Psychiatry. 48: 627-640. PMID 11032974 DOI: 10.1016/S0006-3223(00)00976-8 |
0.424 |
|
| 2000 |
Carlsson A, Waters N, Waters S, Carlsson ML. Network interactions in schizophrenia - Therapeutic implications Brain Research Reviews. 31: 342-349. PMID 10719161 DOI: 10.1016/S0165-0173(99)00050-8 |
0.302 |
|
| 1999 |
Tedroff J, Ekesbo A, Sonesson C, Waters N, Carlsson A. Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease Neurology. 53: 1605-1606. PMID 10534281 DOI: 10.1212/Wnl.53.7.1605 |
0.313 |
|
| 1999 |
Carlsson ML, Martin P, Nilsson M, Sorensen SM, Carlsson A, Waters S, Waters N. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice Journal of Neural Transmission. 106: 123-129. PMID 10226932 DOI: 10.1007/s007020050144 |
0.409 |
|
| 1999 |
Ekesbo A, Torstenson R, Hartvig P, Carlsson A, Sonesson C, Waters N, Tedroff J, Långström B. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains Neuropharmacology. 38: 331-338. PMID 10219971 DOI: 10.1016/S0028-3908(98)00200-7 |
0.426 |
|
| 1998 |
Lahti AC, Weiler M, Carlsson A, Tamminga CA. Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 719-34. PMID 9826114 DOI: 10.1007/S007020050091 |
0.426 |
|
| 1998 |
Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML. Rodent data and general hypothesis: Antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone Journal of Neural Transmission. 105: 365-396. PMID 9720968 DOI: 10.1007/s007020050064 |
0.453 |
|
| 1998 |
Tedroff J, Torstenson R, Hartvig P, Sonesson C, Waters N, Carlsson A, Neu H, Fasth KJ, Långström B. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: Evidence for tone-dependent normalization of striatal dopaminergic activity Synapse. 28: 280-287. PMID 9517836 DOI: 10.1002/(SICI)1098-2396(199804)28:4<280::AID-SYN3>3.0.CO;2-5 |
0.361 |
|
| 1998 |
Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA. Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological Psychiatry. 43: 2-11. PMID 9442338 DOI: 10.1016/S0006-3223(97)00030-9 |
0.379 |
|
| 1997 |
Nilsson M, Carlsson A, Carlsson ML. Glycine and D-serine decrease MK-801-induced hyperactivity in mice Journal of Neural Transmission. 104: 1195-1205. PMID 9503265 DOI: 10.1007/BF01294720 |
0.32 |
|
| 1997 |
Martin P, Waters NR, Waters SE, Carlsson A, Carlsson ML. MK-801-induced hyperlocomotion: Differential effects of m100907, SDZ PSD 958 and raclopride European Journal of Pharmacology. 335: 107-116. PMID 9369362 DOI: 10.1016/S0014-2999(97)01188-6 |
0.419 |
|
| 1997 |
Neu H, Hartvig P, Torstenson R, Fasth KJ, Sonesson C, Waters N, Carlsson A, Tedroff J, Långström B. Synthesis of [11 C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)- OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography Nuclear Medicine and Biology. 24: 507-511. PMID 9316077 DOI: 10.1016/S0969-8051(97)00023-1 |
0.385 |
|
| 1997 |
Martin P, Waters N, Carlsson A, Carlsson ML. The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin Journal of Neural Transmission. 104: 561-564. PMID 9295186 DOI: 10.1007/BF01277672 |
0.35 |
|
| 1997 |
Carlsson A, Hansson LO, Waters N, Carlsson ML. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications Life Sciences. 61: 75-94. PMID 9217267 DOI: 10.1016/S0024-3205(97)00228-2 |
0.307 |
|
| 1997 |
Sonesson C, Wikström H, Smith MW, Svensson K, Carlsson A, Waters N. Regioselective synthesis of 3-aryl substituted pyrrolidines via palladium catalyzed arylation: Pharmacological evaluation for central dopaminergic and serotonergic activity Bioorganic and Medicinal Chemistry Letters. 7: 241-246. DOI: 10.1016/S0960-894X(96)00618-X |
0.357 |
|
| 1997 |
Lahti AC, Lahti RA, Carlsson A, Tamminga CA. The treatment of schizophrenia with partial dopamine agonist: A promising strategy Schizophrenia Research. 24: 207. DOI: 10.1016/S0920-9964(97)82595-9 |
0.344 |
|
| 1996 |
Carlsson A. Stabilizing action of partial dopamine receptor agonists in psychosis European Neuropsychopharmacology. 6: 17. DOI: 10.1016/0924-977X(96)87377-9 |
0.312 |
|
| 1995 |
Svensson A, Carlsson ML, Carlsson A. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice Journal of Neural Transmission. 101: 127-148. PMID 8695043 DOI: 10.1007/BF01271551 |
0.386 |
|
| 1995 |
Kujacic M, Hansson LO, Carlsson A. Acute dopaminergic influence on plasma adrenaline levels in the rat European Journal of Pharmacology. 273: 247-257. PMID 7737332 DOI: 10.1016/0014-2999(94)00699-8 |
0.463 |
|
| 1995 |
Sonesson C, Barf T, Nilsson J, Dijkstra D, Carlsson A, Svensson K, Smith MW, Martin IJ, Duncan JN, King LJ, Wikström H. Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: Central dopamine and serotonin receptor activity Journal of Medicinal Chemistry. 38: 1319-1329. PMID 7731017 DOI: 10.1021/Jm00008A010 |
0.393 |
|
| 1995 |
Kujacic M, Carlsson A. In vivo activity of tyrosine hydroxylase in rat adrenal glands following administration of quinpirole and dopamine European Journal of Pharmacology. 278: 9-15. PMID 7664818 DOI: 10.1016/0014-2999(95)00092-Y |
0.471 |
|
| 1995 |
Carlsson A. Towards a New Understanding of Dopamine Receptors Clinical Neuropharmacology. 18. DOI: 10.1097/00002826-199501001-00002 |
0.41 |
|
| 1995 |
Carlsson A, Piercey MF. Dopamine-Receptor Subtypes in Neurological and Psychiatric Disease: Introduction Clinical Neuropharmacology. 18. DOI: 10.1097/00002826-199501001-00001 |
0.397 |
|
| 1994 |
Waters N, Hansson L, Löfberg L, Carlsson A. Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo European Journal of Pharmacology. 251: 181-190. PMID 8149975 DOI: 10.1016/0014-2999(94)90399-9 |
0.454 |
|
| 1994 |
Sonesson C, Lin C, Hansson L, Waters N, Svensson K, Carlsson A, Smith MW, Wikström H. Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships. Journal of Medicinal Chemistry. 37: 2735-2753. PMID 8064801 DOI: 10.1021/Jm00043A013 |
0.43 |
|
| 1994 |
Stjernlöf P, Elebring T, Nilsson J, Andersson B, Lagerkvist S, Svensson K, Ekman A, Carlsson A, Wikström H. 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists Journal of Medicinal Chemistry. 37: 3263-3273. PMID 7932553 DOI: 10.1021/Jm00046A010 |
0.372 |
|
| 1994 |
Kujacic M, Carlsson A. I. c. v. dopamine fails to alter adrenomedullary function in rats Journal of Neural Transmission. 95: 235-240. PMID 7865178 DOI: 10.1007/BF01271569 |
0.44 |
|
| 1994 |
Carlsson ML, Engberg G, Carlsson A. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice Journal of Neural Transmission. 95: 223-233. PMID 7865177 DOI: 10.1007/BF01271568 |
0.325 |
|
| 1994 |
Martin P, Svensson A, Carlsson A, Carlsson ML. On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801 Journal of Neural Transmission. 95: 113-121. PMID 7865166 DOI: 10.1007/BF01276430 |
0.386 |
|
| 1994 |
Svensson K, Carlsson A, Waters N. Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release Journal of Neural Transmission. 95: 71-74. PMID 7857588 DOI: 10.1007/BF01283032 |
0.444 |
|
| 1994 |
Svensson A, Carlsson ML, Carlsson A. Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone Progress in Neuropsychopharmacology and Biological Psychiatry. 18: 1203-1218. PMID 7846289 DOI: 10.1016/0278-5846(94)90121-X |
0.365 |
|
| 1994 |
Kujacic M, Carlsson A. Influence of GBR 12909 and d-amphetamine on indices of catecholamine synthesis and release in rat adrenal glands Neuropharmacology. 33: 983-987. PMID 7845554 DOI: 10.1016/0028-3908(94)90156-2 |
0.425 |
|
| 1994 |
Svensson K, Carlsson A, Huff RM, Kling-Petersen T, Waters N. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors European Journal of Pharmacology. 263: 235-243. PMID 7843260 DOI: 10.1016/0014-2999(94)90718-8 |
0.467 |
|
| 1994 |
Kujacic M, Carlsson A. Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats Naunyn-Schmiedeberg's Archives of Pharmacology. 350: 245-251. PMID 7824040 DOI: 10.1007/BF00175029 |
0.383 |
|
| 1994 |
Waters N, Löfberg L, Haadsma-Svensson S, Svensson K, Sonesson C, Carlsson A. Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour Journal of Neural Transmission. 98: 39-55. PMID 7710738 DOI: 10.1007/BF01277593 |
0.425 |
|
| 1994 |
Haadsma-Svensson SR, Smith MW, Lin CH, Neil Duncan J, Sonesson C, Wikström H, Waters N, Carlsson A, Svensson K. Synthesis and biological activity of C-5 modified derivatives of (+)-AJ76 and (+)-UH232: Increased dopamine D3 receptor preference and improved pharmacokinetic properties Bioorganic and Medicinal Chemistry Letters. 4: 689-694. DOI: 10.1016/S0960-894X(01)80181-5 |
0.364 |
|
| 1994 |
Lahti A, Lahti R, Carlsson A, Tamminga C. The efficacy of the partial dopamine agonist (-)-3PPP in schizophrenia Biological Psychiatry. 35: 746. DOI: 10.1016/0006-3223(94)91131-2 |
0.35 |
|
| 1993 |
Lin CH, Haadsma-Svensson SR, Phillips G, McCall RB, Piercey MF, Smith MW, Svensson K, Carlsson A, Chidester CG, Von Voigtlander PF. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3-propyl-1H-benz[e]indole-9-carboxamide: A potent and selective 5-HT1A receptor agonist with good oral availability Journal of Medicinal Chemistry. 36: 2208-2218. PMID 8340922 DOI: 10.1021/Jm00067A018 |
0.311 |
|
| 1993 |
Waters N, Lagerkvist S, Löfberg L, Piercey M, Carlsson A. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study. European Journal of Pharmacology. 242: 151-163. PMID 8253112 DOI: 10.1016/0014-2999(93)90075-S |
0.461 |
|
| 1993 |
Sonesson C, Waters N, Svensson K, Carlsson A, Smith MW, Piercey MF, Meier E, Wikström H. Substituted 3-phenylpiperidines: New centrally acting dopamine autoreceptor antagonists Journal of Medicinal Chemistry. 36: 3188-3196. PMID 8230107 DOI: 10.1021/JM00073A021 |
0.364 |
|
| 1993 |
Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A. The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. Journal of Neural Transmission. 94: 11-19. PMID 8129881 DOI: 10.1007/Bf01244979 |
0.449 |
|
| 1993 |
Kujacic M, Carlsson A. Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors Journal of Neural Transmission. 92: 73-79. PMID 8103662 DOI: 10.1007/Bf01244867 |
0.443 |
|
| 1993 |
Svensson K, Eriksson E, Carlsson A. Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects. Neuropharmacology. 32: 1037-1045. PMID 7905192 DOI: 10.1016/0028-3908(93)90069-F |
0.451 |
|
| 1993 |
Carlsson ML, Svensson A, Carlsson A. Differential locomotor interactions between dopamine D1/D2 receptor agonists and NMDA antagonists Schizophrenia Research. 9: 234. DOI: 10.1016/0920-9964(93)90517-M |
0.372 |
|
| 1993 |
Andersson B, Wikström H, Hjorth S, Svensson K, Carlsson A, Sundell S, Lundmark M, Largent B. Resolved 2-arylcyclohexylamines: Effects on reserpine akinesia and central nervous system monoamine synthesis European Journal of Medicinal Chemistry. 28: 63-69. DOI: 10.1016/0223-5234(93)90079-T |
0.536 |
|
| 1992 |
Piercey MF, Lum JT, Hoffmann WE, Carlsson A, Ljung E, Svensson K. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232. Brain Research. 588: 217-222. PMID 1393576 DOI: 10.1016/0006-8993(92)91578-3 |
0.32 |
|
| 1992 |
Svensson A, Carlsson A, Carlsson ML. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice Journal of Neural Transmission. 90: 199-217. PMID 1363051 DOI: 10.1007/BF01250961 |
0.43 |
|
| 1992 |
Svensson A, Carlsson ML, Carlsson A. Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control Journal of Neural Transmission. 88: 235-240. PMID 1358121 DOI: 10.1007/BF01244735 |
0.356 |
|
| 1991 |
Carlsson A, Fornstedt B. Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson's disease Neurology. 41: 50-51. PMID 2041593 DOI: 10.1212/Wnl.41.5_Suppl_2.50 |
0.305 |
|
| 1991 |
Fornstedt B, Carlsson A. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum. Journal of Neurochemistry. 56: 407-414. PMID 1988547 DOI: 10.1111/J.1471-4159.1991.Tb08166.X |
0.347 |
|
| 1991 |
Fornstedt B, Carlsson A. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig. Neuropharmacology. 30: 463-8. PMID 1907723 DOI: 10.1016/0028-3908(91)90007-X |
0.318 |
|
| 1991 |
Svensson A, Carlsson M, Carlsson A. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice Journal of Neural Transmission. 85: 69-77. PMID 1867840 DOI: 10.1007/BF01244659 |
0.401 |
|
| 1991 |
Kullingsjö H, Carlsson A, Svensson K. Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat. European Journal of Pharmacology. 205: 241-246. PMID 1817961 DOI: 10.1016/0014-2999(91)90904-5 |
0.427 |
|
| 1991 |
Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study. Naunyn-Schmiedebergs Archives of Pharmacology. 344: 263-274. PMID 1683686 DOI: 10.1007/Bf00182999 |
0.485 |
|
| 1991 |
Carlsson M, Svensson A, Carlsson A. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice Naunyn-Schmiedeberg's Archives of Pharmacology. 343: 568-573. PMID 1682816 DOI: 10.1007/BF00184286 |
0.37 |
|
| 1991 |
Kujacic M, Svensson K, Löfberg L, Carlsson A. Dopamine receptors, controlling dopamine levels in rat adrenal glands — comparison with central dopaminergic autoreceptors Journal of Neural Transmission. 84: 195-209. PMID 1679336 DOI: 10.1007/Bf01244970 |
0.482 |
|
| 1990 |
Fornstedt B, Pileblad E, Carlsson A. In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age Journal of Neurochemistry. 55: 655-659. PMID 2370552 DOI: 10.1111/J.1471-4159.1990.Tb04183.X |
0.347 |
|
| 1990 |
Allard P, Alafuzoff I, Carlsson A, Eriksson K, Ericson E, Gottfries CG, Marcusson JO. Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease. European Neurology. 30: 181-5. PMID 2209670 DOI: 10.1159/000117341 |
0.302 |
|
| 1990 |
Johansson AM, Fredriksson K, Hacksell U, Grol CJ, Svensson K, Carlsson A, Sundell S. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin. Journal of Medicinal Chemistry. 33: 2925-2929. PMID 2120444 DOI: 10.1021/Jm00172A038 |
0.414 |
|
| 1990 |
Fornstedt B, Bergh I, Rosengren E, Carlsson A. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. Journal of Neurochemistry. 54: 578-86. PMID 2105377 DOI: 10.1111/j.1471-4159.1990.tb01910.x |
0.567 |
|
| 1990 |
Waters N, Löfberg L, Svensson K, Carlsson A. Increased dopamine release by the autoreceptor antagonist (+)-AJ 76 is Ca2(+)-dependent. European Journal of Pharmacology. 187: 425-434. PMID 2073922 DOI: 10.1016/0014-2999(90)90369-H |
0.389 |
|
| 1990 |
Carlsson M, Carlsson A. Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome? Schizophrenia Bulletin. 16: 425-432. PMID 1981107 DOI: 10.1093/Schbul/16.3.425 |
0.329 |
|
| 1990 |
Kujacic M, Svensson K, Löfberg L, Carlsson A. Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists European Journal of Pharmacology. 177: 163-170. PMID 1968848 DOI: 10.1016/0014-2999(90)90266-9 |
0.469 |
|
| 1990 |
Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease Trends in Neurosciences. 13: 272-276. PMID 1695402 DOI: 10.1016/0166-2236(90)90108-M |
0.373 |
|
| 1989 |
Fornstedt B, Brun A, Rosengren E, Carlsson A. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 1: 279-95. PMID 2597314 DOI: 10.1007/BF02263482 |
0.533 |
|
| 1989 |
Waters N, Pettersson G, Carlsson A, Svensson K. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization. Naunyn-Schmiedebergs Archives of Pharmacology. 340: 161-169. PMID 2572972 DOI: 10.1007/Bf00168964 |
0.387 |
|
| 1989 |
Wikström H, Andersson B, Svensson A, Humber LG, Asselin AA, Svensson K, Ekman A, Carlsson A, Nilsson I, Chidester C. Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties Journal of Medicinal Chemistry. 32: 2273-2276. PMID 2571729 DOI: 10.1021/Jm00130A008 |
0.401 |
|
| 1989 |
Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Journal of Neurochemistry. 52: 1170-82. PMID 2564423 DOI: 10.1111/J.1471-4159.1989.Tb01863.X |
0.63 |
|
| 1989 |
Carlsson M, Carlsson A. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice Journal of Neural Transmission. 77: 65-71. PMID 2545813 DOI: 10.1007/Bf01255820 |
0.341 |
|
| 1989 |
Carlsson M, Carlsson A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice Journal of Neural Transmission. 75: 221-226. PMID 2538557 DOI: 10.1007/Bf01258633 |
0.323 |
|
| 1989 |
Fornstedt B, Carlsson A. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment. Journal of Neural Transmission. 76: 155-61. PMID 2496196 DOI: 10.1007/BF01578755 |
0.304 |
|
| 1988 |
Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Lindberg P, Andersson B. N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 31: 92-9. PMID 3336037 |
0.668 |
|
| 1988 |
Pileblad E, Carlsson A. Studies on the Acute and Long-Term Changes in Dopamine and Noradrenaline Metabolism in Mouse Brain Following Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Pharmacology & Toxicology. 62: 213-222. PMID 3260379 DOI: 10.1111/J.1600-0773.1988.Tb01875.X |
0.444 |
|
| 1988 |
Hajós M, Engberg G, Nissbrandt H, Magnusson T, Carlsson A. Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum. Journal of Neural Transmission. 74: 129-39. PMID 3210010 DOI: 10.1007/BF01244779 |
0.593 |
|
| 1988 |
Hjorth S, Clark D, Carlsson A. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. European Journal of Pharmacology. 152: 207-15. PMID 3146512 DOI: 10.1016/0014-2999(88)90715-7 |
0.676 |
|
| 1988 |
Nissbrandt H, Engberg G, Wikström H, Magnusson T, Carlsson A. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 148-61. PMID 3141816 DOI: 10.1007/BF00174863 |
0.646 |
|
| 1988 |
Hajos M, Hjorth S, Svensson K, Carlsson A. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion. Experimental Brain Research. 70: 577-84. PMID 3133239 DOI: 10.1007/BF00247605 |
0.591 |
|
| 1988 |
Hjorth S, Carlsson A. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390. Journal of Neural Transmission. 72: 83-97. PMID 2968439 DOI: 10.1007/BF01250232 |
0.599 |
|
| 1988 |
Wikstrom H, Elebring T, Hallnemo G, Andersson B, Svensson K, Carlsson A, Rollema H. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin Journal of Medicinal Chemistry. 31: 1080-1084. PMID 2967374 DOI: 10.1021/Jm00401A005 |
0.302 |
|
| 1988 |
Snape BM, Pileblad E, Ekman A, Magnusson T, Carlsson A, Engel J. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices. The Journal of Pharmacy and Pharmacology. 40: 620-6. PMID 2907028 DOI: 10.1111/j.2042-7158.1988.tb05321.x |
0.715 |
|
| 1988 |
Eriksson T, Carlsson A. β-adrenergic control of brain uptake of large neutral amino acids Life Sciences. 42: 1583-1589. PMID 2835561 DOI: 10.1016/0024-3205(88)90436-5 |
0.303 |
|
| 1988 |
Carlsson M, Carlsson A. In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats. Naunyn-Schmiedebergs Archives of Pharmacology. 338: 345-349. PMID 2469019 DOI: 10.1007/Bf00172108 |
0.318 |
|
| 1988 |
Carlsson M, Carlsson A. A regional study of sex differences in rat brain serotonin Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 53-61. PMID 2452455 DOI: 10.1016/0278-5846(88)90061-9 |
0.347 |
|
| 1987 |
Carlsson M, Carlsson A, Eriksson E. The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats. European Journal of Pharmacology. 142: 39-43. PMID 3691635 DOI: 10.1016/0014-2999(87)90651-0 |
0.404 |
|
| 1987 |
Johansson AM, Nilsson JL, Karlén A, Hacksell U, Sanchez D, Svensson K, Hjorth S, Carlsson A, Sundell S, Kenne L. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors. Journal of Medicinal Chemistry. 30: 1827-37. PMID 3656358 DOI: 10.1021/JM00393A025 |
0.567 |
|
| 1987 |
Johansson AM, Nilsson JLG, Karlen A, Hacksell U, Svensson K, Carlsson A, Kenne L, Sundell S. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation. Journal of Medicinal Chemistry. 30: 1135-1144. PMID 3599021 DOI: 10.1021/Jm00390A004 |
0.425 |
|
| 1987 |
Svensson K, Alföldi P, Hajós M, Rubicsek G, Johansson AM, Carlsson A, Obál F. Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat. Pharmacology, Biochemistry and Behavior. 26: 123-129. PMID 3562484 DOI: 10.1016/0091-3057(87)90544-2 |
0.304 |
|
| 1987 |
Johansson AM, Arvidsson L-, Hacksell U, Nilsson JLG, Svensson K, Carlsson A. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists. Journal of Medicinal Chemistry. 30: 602-611. PMID 3560156 DOI: 10.1021/Jm00387A004 |
0.439 |
|
| 1987 |
Ahlenius S, Carlsson A, Hillegaart V, Hjorth S, Larsson K. Region-selective activation of brain monoamine synthesis by sexual activity in the male rat. European Journal of Pharmacology. 144: 77-82. PMID 3436362 DOI: 10.1016/0014-2999(87)90011-2 |
0.574 |
|
| 1987 |
Hjorth S, Carlsson A, Engel JA. Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm. Psychopharmacology. 92: 371-5. PMID 3114790 DOI: 10.1007/BF00210846 |
0.685 |
|
| 1987 |
Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 30: 2105-9. PMID 2959776 DOI: 10.1021/Jm00394A029 |
0.697 |
|
| 1987 |
Hjorth S, Carlsson A. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393. Psychopharmacology. 93: 534-7. PMID 2893419 DOI: 10.1007/BF00207249 |
0.554 |
|
| 1987 |
Wikström H, Andersson B, Elebring T, Svensson K, Carlsson A, Largent B. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors. Journal of Medicinal Chemistry. 30: 2169-74. PMID 2824773 DOI: 10.1021/Jm00395A002 |
0.375 |
|
| 1987 |
Hajós M, Hjorth S, Carlsson A. Injection of capsaicin into the nucleus raphe dorsalis elicits heat loss in the rat. Neuroscience Letters. 75: 199-204. PMID 2437500 DOI: 10.1016/0304-3940(87)90297-7 |
0.542 |
|
| 1987 |
Pileblad E, Carlsson A. In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain. Journal of Neural Transmission. 66: 171-87. PMID 2431107 DOI: 10.1007/BF01260912 |
0.323 |
|
| 1986 |
Svensson K, Carlsson A, Johansson AM, Arvidsson LE, Nilsson JLG. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors. Journal of Neural Transmission. 65: 29-38. PMID 3958706 DOI: 10.1007/Bf01249609 |
0.46 |
|
| 1986 |
Gottfries C, Bartfai T, Carlsson A, Eckerkäs S, Svennerholm L. Multiple biochemical deficits in both gray and white matter of Alzheimer brains Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 405-413. PMID 3797685 DOI: 10.1016/0278-5846(86)90014-X |
0.319 |
|
| 1986 |
Svensson K, Carlsson M, Carlsson A, Hjorth S, Johansson AM, Eriksson E. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats. European Journal of Pharmacology. 130: 237-42. PMID 3792447 DOI: 10.1016/0014-2999(86)90273-6 |
0.658 |
|
| 1986 |
Carlsson W, Eriksson E, Nilsson C, Carlsson A. Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion Neuropharmacology. 25: 951-954. PMID 3774120 DOI: 10.1016/0028-3908(86)90028-6 |
0.355 |
|
| 1986 |
Hjorth S, Svensson K, Carlsson A, Wikström H, Andersson B. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP. Naunyn-Schmiedeberg's Archives of Pharmacology. 333: 205-18. PMID 3762735 DOI: 10.1007/Bf00512931 |
0.657 |
|
| 1986 |
Rollema H, Mastebroek D, Wikstrom H, Svensson K, Carlsson A, Sundell S. Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics. Journal of Medicinal Chemistry. 29: 1889-1895. PMID 3761308 DOI: 10.1021/Jm00160A016 |
0.342 |
|
| 1986 |
Fornstedt B, Rosengren E, Carlsson A. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology. 25: 451-4. PMID 3086766 DOI: 10.1016/0028-3908(86)90242-X |
0.576 |
|
| 1986 |
Svensson K, Hjorth S, Clark D, Carlsson A, Wikström H, Andersson B, Sanchez D, Johansson AM, Arvidsson LE, Hacksell U. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. Journal of Neural Transmission. 65: 1-27. PMID 3083041 DOI: 10.1007/BF01249608 |
0.619 |
|
| 1986 |
Hjorth S, Engel JA, Carlsson A. Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat. Pharmacology, Biochemistry, and Behavior. 24: 237-40. PMID 3006085 DOI: 10.1016/0091-3057(86)90344-8 |
0.699 |
|
| 1986 |
Svensson K, Johansson AM, Magnusson T, Carlsson A. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn-Schmiedeberg's Archives of Pharmacology. 334: 234-45. PMID 2880302 DOI: 10.1007/BF00508777 |
0.658 |
|
| 1986 |
Hjorth S, Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? European Journal of Pharmacology. 129: 131-8. PMID 2429847 DOI: 10.1016/0014-2999(86)90344-4 |
0.588 |
|
| 1986 |
Eriksson T, Wiesel K, Carlsson A. Rat brain concentration of administered amino acids: dependence on time of day for administration. Journal of Neural Transmission. 65: 83-91. PMID 2420927 DOI: 10.1007/Bf01249614 |
0.31 |
|
| 1985 |
Carlsson A, Löfberg L. In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum. Journal of Neural Transmission. 64: 173-185. PMID 4086990 DOI: 10.1007/Bf01256465 |
0.346 |
|
| 1985 |
Clark D, Engberg G, Pileblad E, Svensson TH, Carlsson A, Freeman AS, Bunney BS. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Naunyn-Schmiedeberg's Archives of Pharmacology. 329: 344-54. PMID 4033804 DOI: 10.1007/BF00496366 |
0.551 |
|
| 1985 |
Hjorth S, Carlsson A, Clark D, Svensson K, Sanchez D. Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP. European Journal of Pharmacology. 107: 299-304. PMID 3979430 DOI: 10.1016/0014-2999(85)90254-7 |
0.692 |
|
| 1985 |
Wikström H, Andersson B, Sanchez D, Lindberg P, Arvidsson LE, Johansson AM, Nilsson JL, Svensson K, Hjorth S, Carlsson A. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists. Journal of Medicinal Chemistry. 28: 215-25. PMID 3968686 DOI: 10.1021/Jm00380A012 |
0.625 |
|
| 1985 |
Hjorth S, Clark D, Svensson K, Carlsson A, Thorberg O. Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes. Journal of Neural Transmission. 64: 187-98. PMID 3936899 DOI: 10.1007/Bf01256466 |
0.638 |
|
| 1985 |
Clark D, Hjorth S, Carlsson A. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. Journal of Neural Transmission. 62: 1-52. PMID 3894582 DOI: 10.1007/Bf01260414 |
0.646 |
|
| 1985 |
Carlsson A. Pharmacological properties of presynaptic dopamine receptor agonists Psychopharmacology. Supplementum. 2: 31-38. PMID 3858802 DOI: 10.1007/978-3-642-70140-5_4 |
0.337 |
|
| 1985 |
Rosengren E, Linder-Eliasson E, Carlsson A. Detection of 5-S-cysteinyldopamine in human brain. Journal of Neural Transmission. 63: 247-53. PMID 3840838 DOI: 10.1007/BF01252029 |
0.56 |
|
| 1985 |
Nissbrandt H, Pileblad E, Carlsson A. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra. Journal of Pharmacy and Pharmacology. 37: 884-889. PMID 2868096 DOI: 10.1111/J.2042-7158.1985.Tb04994.X |
0.43 |
|
| 1985 |
Hjorth S, Carlsson A. (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacology. 24: 1143-6. PMID 2867485 DOI: 10.1016/0028-3908(85)90207-2 |
0.541 |
|
| 1985 |
Clark D, Hjorth S, Carlsson A. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. Journal of Neural Transmission. 62: 171-207. PMID 2863323 DOI: 10.1007/Bf01252236 |
0.626 |
|
| 1985 |
Pileblad E, Fornstedt B, Clark D, Carlsson A. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum. The Journal of Pharmacy and Pharmacology. 37: 707-11. PMID 2416901 DOI: 10.1111/J.2042-7158.1985.Tb04947.X |
0.44 |
|
| 1985 |
Carlsson M, Svensson K, Eriksson E, Carlsson A. Rat brain serotonin: Biochemical and functional evidence for a sex difference Journal of Neural Transmission. 63: 297-313. PMID 2415675 DOI: 10.1007/Bf01252033 |
0.316 |
|
| 1985 |
Hjorth S, Clark D, Carlsson A. Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations. Life Sciences. 37: 673-84. PMID 2410756 DOI: 10.1016/0024-3205(85)90435-7 |
0.684 |
|
| 1985 |
Johansson AM, Arvidsson L-, Hacksell U, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B, Wikstroem H. Novel Dopamine Receptor Agonists And Antagonists With Preferential Action On Autoreceptors Cheminform. 16. DOI: 10.1002/Chin.198548162 |
0.635 |
|
| 1985 |
Wikstroem H, Andersson B, Sanchez D, Lindberg P, Arvidsson L-, Johansson AM, Nilsson JLG, Svensson K, Hjorth S, Carlsson A. Resolved Monophenolic 2-Aminotetralins And 1,2,3,4,4A,5,6,10B-Octahydrobenzo(F)Quinolines: Structural And Stereochemical Considerations For Centrally Acting Pre- And Postsynaptic Dopamine-Receptor Agonists Cheminform. 16. DOI: 10.1002/Chin.198524182 |
0.581 |
|
| 1985 |
Wikstroem H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson AM, Thorberg S-, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A. Resolved 3-(3-Hydroxyphenyl)-N-N-Propylpiperidine And Its Analogs: Central Dopamine Receptor Activity Cheminform. 16. DOI: 10.1002/Chin.198503222 |
0.596 |
|
| 1985 |
Hacksell U, Johansson AM, Arvidsson L-, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Sanchez D, Lindberg P. C1-Methylated 5-Hydroxy-2-(Dipropylamino)Tetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 16. DOI: 10.1002/Chin.198503183 |
0.61 |
|
| 1984 |
Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 27: 1003-7. PMID 6431102 DOI: 10.1021/Jm00374A012 |
0.647 |
|
| 1984 |
Eriksson T, Magnusson T, Carlsson A, Linde A, Granérus AK. "On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma. Journal of Neural Transmission. 59: 229-40. PMID 6429277 DOI: 10.1007/BF01250010 |
0.517 |
|
| 1984 |
Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 27: 45-51. PMID 6418888 DOI: 10.1021/Jm00367A009 |
0.593 |
|
| 1984 |
Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). European Journal of Pharmacology. 105: 365-8. PMID 6239785 DOI: 10.1016/0014-2999(84)90634-4 |
0.677 |
|
| 1984 |
Clark D, Hjorth S, Carlsson A. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. European Journal of Pharmacology. 106: 185-9. PMID 6099268 DOI: 10.1016/0014-2999(84)90694-0 |
0.68 |
|
| 1984 |
Pileblad E, Nissbrandt H, Carlsson A. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (NMPTP) in mouse brain Journal of Neural Transmission. 60: 199-203. DOI: 10.1007/978-1-349-07431-0_54 |
0.35 |
|
| 1984 |
Arvidsson L-, Hacksell U, Johansson AM, Nilsson JLG, Lindberg P, Sanchez D, Wikstroem H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(Alkylamino)Tetralins And Related Compounds As Central 5-Hydroxytryptamine Receptor Agonists Cheminform. 15. DOI: 10.1002/Chin.198424168 |
0.561 |
|
| 1983 |
Häggström JE, Gunne LM, Carlsson A, Wikström H. Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias Journal of Neural Transmission. 58: 135-142. PMID 6663299 DOI: 10.1007/Bf01252800 |
0.363 |
|
| 1983 |
Eriksson E, Modigh K, Carlsson A, Wikström H. Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers. European Journal of Pharmacology. 96: 29-36. PMID 6662196 DOI: 10.1016/0014-2999(83)90525-3 |
0.476 |
|
| 1983 |
Eriksson T, Magnusson T, Carlsson A, Hagman M, Jagenburg R. Decrease in plasma amino acids in man after an acute dose of ethanol. Journal of Studies On Alcohol. 44: 215-21. PMID 6645507 DOI: 10.15288/Jsa.1983.44.215 |
0.455 |
|
| 1983 |
Carlsson A. Dopamine receptor agonists: Intrinsic activity vs. state of receptor Journal of Neural Transmission. 57: 309-315. PMID 6418858 DOI: 10.1007/BF01249001 |
0.415 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology. 81: 89-99. PMID 6415751 DOI: 10.1007/BF00428999 |
0.604 |
|
| 1983 |
Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P. The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology. 81: 14-7. PMID 6138790 DOI: 10.1007/BF00439266 |
0.734 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson A, Nilsson JLG. The search for selective dopaminergic autoreceptor agonists. Journal of Neural Transmission-Supplement. 18: 131-137. DOI: 10.1007/978-3-7091-4408-4_12 |
0.635 |
|
| 1983 |
Wikstroem H, Sanchez D, Lindberg P, Arvidsson L-, Hacksell U, Johansson A, Nilsson JLG, Hjorth S, Carlsson A. Monophenolic Octahydrobenzo(F)Quinolines: Central Dopamine- And Serotonin-Receptor Stimulating Activity Cheminform. 14. DOI: 10.1002/Chin.198303246 |
0.612 |
|
| 1982 |
Eriksson T, Carlsson A. Adrenergic influence on rat plasma concentrations of tyrosine and tryptophan. Life Sciences. 30: 1465-1472. PMID 7087675 DOI: 10.1016/0024-3205(82)90560-4 |
0.317 |
|
| 1982 |
Sakabe T, Dahlgren N, Carlsson A, Siesjö BK. Effect of diazepam on cerebral monoamine synthesis during hypoxia and hypercapnia in the rat Acta Physiologica Scandinavica. 115: 57-65. PMID 6814196 DOI: 10.1111/J.1748-1716.1982.Tb07045.X |
0.359 |
|
| 1982 |
Eriksson T, Carlsson A. Isoprenaline increases brain concentrations of administered L-dopa and L-tryptophan in the rat. Psychopharmacology. 77: 98-100. PMID 6812125 DOI: 10.1007/Bf00436106 |
0.325 |
|
| 1982 |
Jackson D, Carlsson A, Hjorth S, Lindberg P. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine). Journal of Neural Transmission. 53: 233-45. PMID 6286867 DOI: 10.1007/Bf01252035 |
0.618 |
|
| 1982 |
Hjorth S, Carlsson A. Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings. European Journal of Pharmacology. 83: 299-303. PMID 6129148 DOI: 10.1016/0014-2999(82)90265-5 |
0.626 |
|
| 1982 |
Clark D, Carlsson A, Hjorth S, Svensson K, Engel J, Sanchez D. Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies. European Journal of Pharmacology. 83: 131-4. PMID 6127226 DOI: 10.1016/0014-2999(82)90297-7 |
0.702 |
|
| 1982 |
Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson LE, Hacksell U, Nilsson JLG. 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity Journal of Neural Transmission. 55: 169-188. DOI: 10.1007/Bf01276574 |
0.582 |
|
| 1982 |
Nyberg P, Carlsson A, Winblad B. Brain monoamines in cases with Down's syndrome with and without dementia Journal of Neural Transmission. 55: 289-299. DOI: 10.1007/Bf01243450 |
0.362 |
|
| 1982 |
Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Sanchez D, Wikstroem H, Lindberg P, Hjorth S, Carlsson A. 3-Phenylpiperidines. Central Dopamine-Autoreceptor Stimulating Activity Cheminform. 13. DOI: 10.1002/Chin.198222234 |
0.605 |
|
| 1982 |
Arvidsson L-, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstroem H. 8-Hydroxy-2-(Dipropylamino)Tetralin, A New Centrally Acting 5-Hydroxytryptamine Receptor Agonist Cheminform. 13. DOI: 10.1002/Chin.198203137 |
0.571 |
|
| 1981 |
Eriksson T, Magnusson T, Carlsson A, Hagman M, Jagenburg R, Edén S. Effects of hypophysectomy, adrenalectomy and (-)-propranolol on ethanol-induced decrease in plasma amino acids. Naunyn-Schmiedeberg's Archives of Pharmacology. 317: 214-8. PMID 7322213 DOI: 10.1007/BF00503819 |
0.48 |
|
| 1981 |
Carlsson A, Fowler CJ, Magnusson T, Oreland L, Wiberg A. The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransection. Naunyn-Schmiedeberg's Archives of Pharmacology. 316: 51-5. PMID 7279004 DOI: 10.1007/BF00507227 |
0.545 |
|
| 1981 |
Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Wikström H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 24: 429-34. PMID 7265130 DOI: 10.1021/Jm00136A012 |
0.625 |
|
| 1981 |
Carlsson A. Some current problems related to the mode of action of antidepressant drugs Acta Psychiatrica Scandinavica. 63: 63-66. PMID 6939325 DOI: 10.1111/J.1600-0447.1981.Tb00709.X |
0.354 |
|
| 1981 |
Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 24: 921-3. PMID 6460101 DOI: 10.1021/Jm00140A002 |
0.571 |
|
| 1981 |
Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacology, Biochemistry, and Behavior. 15: 785-92. PMID 6458826 DOI: 10.1016/0091-3057(81)90023-X |
0.565 |
|
| 1981 |
Hjorth S, Carlsson A, Wikström H, Lindberg P, Sanchez D, Hacksell U, Arvidsson LE, Svensson U, Nilsson JL. 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sciences. 28: 1225-38. PMID 6112651 DOI: 10.1016/0024-3205(81)90448-3 |
0.67 |
|
| 1981 |
Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Wikstroem H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(Dipropylamino)Indans And Related Compounds: Central Dopamine-Receptor Stimulating Activity Cheminform. 12. DOI: 10.1002/Chin.198134192 |
0.614 |
|
| 1980 |
Oreland L, Fowler CJ, Carlsson A, Magnusson T. Monoamine oxidase -A and -B activity in the rat brain after hemitransection. Life Sciences. 26: 139-46. PMID 7366322 DOI: 10.1016/0024-3205(80)90058-2 |
0.541 |
|
| 1980 |
GarcÃa-Sevilla JA, Magnusson T, Carlsson A. Effects of enkephalins and two enzyme resistant analogues on monoamine synthesis and metabolism in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 310: 211-8. PMID 6103517 DOI: 10.1007/Bf00499912 |
0.602 |
|
| 1980 |
Hacksell U, Svensson U, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Lindberg P, Sanchez D. N-Alkylated 2-Aminotetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 11. DOI: 10.1002/Chin.198015191 |
0.622 |
|
| 1979 |
Garcia-Sevilla JA, Magnusson T, Carlsson A. Opposite effects of naloxone on substance P-induced changes in brain DOPA synthesis and in locomotor activity in rats. Journal of Neural Transmission. 45: 185-93. PMID 479872 DOI: 10.1007/Bf01244407 |
0.609 |
|
| 1979 |
Agardh C, Carlsson A, Linqvist M, Siesjö B. The effect of pronounced hypoglycemia on monoamine metabolism in rat brain Diabetes. 28: 804-809. PMID 467805 DOI: 10.2337/Diab.28.9.804 |
0.386 |
|
| 1979 |
Ahtee L, Carlsson A. Dual action of methadone on 5-HT synthesis and metabolism. Naunyn-Schmiedebergs Archives of Pharmacology. 307: 51-56. PMID 314596 DOI: 10.1007/Bf00506551 |
0.332 |
|
| 1979 |
Carlsson A, Lindqvist M. Effects of antidepressant agents on the synthesis of brain monoamines. Journal of Neural Transmission. 43: 73-91. PMID 215722 DOI: 10.1007/BF01579067 |
0.326 |
|
| 1979 |
Engel J, Ahlenius S, Almgren O, Carlsson A, Larsson K, Södersten P. Effects of gonadectomy and hormone replacement on brain monoamine synthesis in male rats. Pharmacology, Biochemistry and Behavior. 10: 149-154. PMID 35791 DOI: 10.1016/0091-3057(79)90181-3 |
0.551 |
|
| 1979 |
Wikstroem H, Lindberg P, Martinson P, Hjorth S, Carlsson A, Hacksell U, Svensson U, Nilsson JLG. Pivaloyl Esters Of N,N‐Dialkylated Dopamine Congeners. Central Dopamine‐Receptor Stimulating Activity Cheminform. 10. DOI: 10.1002/Chin.197908144 |
0.601 |
|
| 1978 |
GarcÃa-Sevilla JA, Magnusson T, Carlsson A, Leban J, Folkers K. Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover. Naunyn-Schmiedeberg's Archives of Pharmacology. 305: 213-8. PMID 740049 DOI: 10.1007/Bf00498813 |
0.596 |
|
| 1978 |
Calderini G, Carlsson A, Nordstro¨m C. Influence of transient ischemia on monoamine metabolism in the rat brain during nitrous oxide and phenobarbitone anaesthesia. Brain Research. 157: 303-310. PMID 309781 DOI: 10.1016/0006-8993(78)90032-X |
0.385 |
|
| 1978 |
Calderini G, Carlsson A, Nordstro¨m C. Monoamine metabolism during bicuculline-induced epileptic seizures in the rat Brain Research. 157: 295-302. PMID 309780 DOI: 10.1016/0006-8993(78)90031-8 |
0.383 |
|
| 1978 |
Garcia-Sevilla JA, Magnusson T, Carlsson A. Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover. Brain Research. 155: 159-64. PMID 308386 DOI: 10.1016/0006-8993(78)90318-9 |
0.552 |
|
| 1978 |
Biswas B, Carlsson A. On the mode of action of diazepam on brain catecholamine metabolism Naunyn-Schmiedeberg's Archives of Pharmacology. 303: 73-78. PMID 307697 DOI: 10.1007/BF00496187 |
0.393 |
|
| 1978 |
Biswas B, Carlsson A. Effect of intraperitoneally administered GABA on the locomotor activity of mice Psychopharmacology. 59: 91-94. PMID 100821 DOI: 10.1007/BF00428037 |
0.303 |
|
| 1978 |
Garcia-Sevilla JA, Ahtee L, Magnusson T, Carlsson A. Opiate-receptor mediated changes in monoamine synthesis in rat brain. The Journal of Pharmacy and Pharmacology. 30: 613-21. PMID 30814 DOI: 10.1111/J.2042-7158.1978.Tb13342.X |
0.613 |
|
| 1978 |
Biswas B, Carlsson A. Potentiation by neuroleptic agents of the inhibitory action of intraperitoneally administered GABA on the locomotor activity of mice Pharmacology, Biochemistry and Behavior. 8: 651-654. PMID 29313 DOI: 10.1016/0091-3057(78)90261-7 |
0.364 |
|
| 1977 |
Ohman R, Larsson M, Nilsson IM, Engel J, Carlsson A. Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 105-14. PMID 909609 DOI: 10.1007/BF00498552 |
0.508 |
|
| 1977 |
Biswas B, Carlsson A. The effect of intraperitoneally administered GABA on brain monoamine metabolism Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 47-51. PMID 904694 DOI: 10.1007/BF00508636 |
0.383 |
|
| 1977 |
Biswas B, Carlsson A. The effect of intracerebroventricularly administered GABA on brain monoamine metabolism Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 41-46. PMID 904693 DOI: 10.1007/BF00508635 |
0.372 |
|
| 1977 |
Strömbom U, Svensson TH, Carlsson A. Antagonism of Ethanol's Central Stimulation in Mice by Small Doses of Catecholamine-Receptor Agonists Psychopharmacology. 51: 293-299. PMID 403547 DOI: 10.1007/Bf00431639 |
0.355 |
|
| 1977 |
Carlsson A, Kehr W, Lindqvist M. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation. Journal of Neural Transmission. 40: 99-113. PMID 323424 DOI: 10.1007/Bf01250562 |
0.438 |
|
| 1977 |
Kehr W, Carlsson A, Lindqvist M. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol. Naunyn-Schmiedebergs Archives of Pharmacology. 297: 111-117. PMID 193050 DOI: 10.1007/Bf00499920 |
0.398 |
|
| 1977 |
Carlsson A, Holmin T, Lindqvist M, Siesjo BK. Effect of hypercapnia and hypocapnia on tryptophan and tyrosine hydroxylation in rat brain. Acta Physiologica Scandinavica. 99: 503-509. PMID 16438 DOI: 10.1111/J.1748-1716.1977.Tb10404.X |
0.345 |
|
| 1976 |
Carlsson A, Kehr W, Lindqvist M. The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. Journal of Neural Transmission. 39: 1-19. PMID 1086343 DOI: 10.1007/Bf01248762 |
0.434 |
|
| 1976 |
Cott J, Carlsson A, Engel J, Lindqvist M. Suppression of ethanol-induced locomotor stimulation by GABA-like drugs Naunyn-Schmiedeberg's Archives of Pharmacology. 295: 203-209. PMID 1012342 DOI: 10.1007/BF00505087 |
0.76 |
|
| 1976 |
Kehr W, Lindqvist M, Carlsson A. Distribution of Dopamine in the rat cerebral cortex Journal of Neural Transmission. 38: 173-180. PMID 956808 DOI: 10.1007/Bf01249437 |
0.353 |
|
| 1976 |
Almgren O, Snider SR, Carlsson A. Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment Naunyn-Schmiedebergs Archives of Pharmacology. 292: 133-136. PMID 940594 DOI: 10.1007/Bf00498583 |
0.417 |
|
| 1976 |
Wålinder J, Skott A, Carlsson A, Roos B. Potentiation by Metyrosine of Thioridazine Effects in Chronic Schizophrenics: A Long-Term Trial Using Double-Blind Crossover Technique Archives of General Psychiatry. 33: 501-505. PMID 779704 DOI: 10.1001/Archpsyc.1976.01770040061011 |
0.31 |
|
| 1976 |
Magnusson T, Carlsson A, Fisher GH, Chang D, Folkers K. Effect of synthetic substance P on monoaminergic mechanisms in brain. Journal of Neural Transmission. 38: 89-93. PMID 5576 DOI: 10.1007/Bf01262967 |
0.591 |
|
| 1975 |
Ahlenius S, Carlsson A, Engel J. Antagonism by baclophen of the d-amphetamine-induced disruption of a successive discrimination in the rat. Journal of Neural Transmission. 36: 327-333. PMID 1165490 DOI: 10.1007/Bf01253132 |
0.549 |
|
| 1975 |
Lindqvist M, Kehr W, Carlsson A. Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain. Journal of Neural Transmission. 36: 161-176. PMID 1080799 DOI: 10.1007/Bf01253123 |
0.327 |
|
| 1975 |
Brown RM, Kehr W, Carlsson A. Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia. Brain Research. 85: 491-509. PMID 236073 DOI: 10.1016/0006-8993(75)90822-7 |
0.446 |
|
| 1975 |
Waldeck B, Snider SR, Brown R, Carlsson A. Studies on the synthesis and subcellular distribution of dopamine in the rat adrenal medulla Naunyn-Schmiedebergs Archives of Pharmacology. 287: 1-10. PMID 235101 DOI: 10.1007/Bf00632633 |
0.38 |
|
| 1974 |
Brown RM, Snider SR, Carlsson A. Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress II. The central nervous system Journal of Neural Transmission. 35: 293-305. PMID 4548084 DOI: 10.1007/Bf02205226 |
0.375 |
|
| 1974 |
Snider SR, Brown RM, Carlsson A. Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress I. The adrenal medulla Journal of Neural Transmission. 35: 283-291. PMID 4474359 DOI: 10.1007/Bf02205225 |
0.369 |
|
| 1974 |
Carlsson A, Lindqvist M, Kehr W. Postmortal accumulation of 3-methoxytyramine in brain. Naunyn-Schmiedebergs Archives of Pharmacology. 284: 365-372. PMID 4281061 DOI: 10.1007/Bf00504705 |
0.36 |
|
| 1974 |
Lindqvist M, Kehr W, Carlsson A. Effect of pentobarbitone and diethyl ether on the synthesis of monoamines in rat brain Naunyn-Schmiedebergs Archives of Pharmacology. 284: 263-277. PMID 4279353 DOI: 10.1007/Bf00500346 |
0.387 |
|
| 1974 |
Carlsson A, Engel J, Strömbom U, Svensson TH, Waldeck B. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn-Schmiedeberg's Archives of Pharmacology. 283: 117-28. PMID 4278296 DOI: 10.1007/BF00501138 |
0.601 |
|
| 1973 |
Carlsson A, Magnusson T, Svensson TH, Waldeck B. Effect of ethanol on the metabolism of brain catecholamines. Psychopharmacologia. 30: 27-36. PMID 4735977 DOI: 10.1007/BF00422791 |
0.571 |
|
| 1973 |
Ahlenius S, Carlsson A, Engel J, Svensson T, dersten PS. Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man Clinical Pharmacology & Therapeutics. 14: 586-591. PMID 4723267 DOI: 10.1002/Cpt1973144Part1586 |
0.447 |
|
| 1973 |
Davis JN, Carlsson A. Effect of hypoxia on tyrosine and tryptophan hydroxylation in unanaesthetized rat brain. Journal of Neurochemistry. 20: 913-5. PMID 4703804 DOI: 10.1111/j.1471-4159.1973.tb00055.x |
0.443 |
|
| 1973 |
Davis JN, Carlsson A, MacMillan V, Siesjö BK. Brain tryptophan hydroxylation: dependence on arterial oxygen tension. Science (New York, N.Y.). 182: 72-4. PMID 4542339 DOI: 10.1126/Science.182.4107.72 |
0.479 |
|
| 1973 |
Carlsson A, Lindqvist M, Magnusson T, Atack C. Effect of acute transection on the synthesis and turnover of 5-HT in the rat spinal cord. Naunyn-Schmiedeberg's Archives of Pharmacology. 277: 1-12. PMID 4350468 DOI: 10.1007/BF00498780 |
0.536 |
|
| 1973 |
Davis JN, Carlsson A. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain. Journal of Neurochemistry. 21: 783-90. PMID 4148239 DOI: 10.1111/j.1471-4159.1973.tb07522.x |
0.44 |
|
| 1973 |
Carlsson A, Lindqvist M. In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. Journal of Neural Transmission. 34: 79-91. PMID 4146642 DOI: 10.1007/Bf01244661 |
0.332 |
|
| 1973 |
Carlsson A, Roos BE, Wålinder J, Skott A. Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics. Journal of Neural Transmission. 34: 125-132. PMID 4146641 DOI: 10.1007/Bf01244665 |
0.308 |
|
| 1973 |
Carlsson A, Lindqvist M. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. Journal of Pharmacy and Pharmacology. 25: 437-440. PMID 4146580 DOI: 10.1111/J.2042-7158.1973.Tb09129.X |
0.37 |
|
| 1973 |
Snider SR, Almgren O, Carlsson A. The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat. Naunyn-Schmiedebergs Archives of Pharmacology. 278: 1-12. PMID 4145469 DOI: 10.1007/Bf00501858 |
0.42 |
|
| 1973 |
Carlsson A, Snider SR, Almgren O. The neurogenic short-term control of catecholamine synthesis and release in the sympatho-adrenal systems, as reflected in the levels of endogenous dopamine and β-hydroxylated catecholamines Life Sciences. 13: 551-556. DOI: 10.1016/0024-3205(73)90244-0 |
0.408 |
|
| 1972 |
Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Archives of Pharmacology. 275: 153-68. PMID 4404948 DOI: 10.1007/Bf00508904 |
0.551 |
|
| 1972 |
Kehr W, Carlsson A, Lindqvist M, Magnusson T, Atack C. Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. The Journal of Pharmacy and Pharmacology. 24: 744-7. PMID 4404084 DOI: 10.1111/J.2042-7158.1972.Tb09104.X |
0.574 |
|
| 1972 |
Carlsson A, Engel J, Svensson TH. Inhibition of ethanol-induced excitation in mice and rats by α-methyl-p-tyrosine Psychopharmacology. 26: 307-312. PMID 4403706 DOI: 10.1007/Bf00422706 |
0.53 |
|
| 1972 |
Carlsson A, Bédard P, Lindqvist M, Magnusson T. The influence of nerve-impulse flow on the synthesis and metabolism of hydroxytryptamine. The Biochemical Journal. 128: 70P-71P. PMID 4344007 DOI: 10.1042/Bj1280070P |
0.495 |
|
| 1972 |
Carlsson A, Lindqvist M. The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo Journal of Neural Transmission. 33: 23-43. PMID 4264576 DOI: 10.1007/Bf01244726 |
0.333 |
|
| 1972 |
Kehr W, Carlsson A, Lindqvist M. A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedebergs Archives of Pharmacology. 274: 273-280. PMID 4262782 DOI: 10.1007/Bf00501936 |
0.305 |
|
| 1972 |
Carlsson A, Waldeck B. Formation of dopamine from 3-methoxytyrosine. Fact or artifact? Naunyn-Schmiedebergs Archives of Pharmacology. 272: 441-446. PMID 4260264 DOI: 10.1007/Bf00501250 |
0.369 |
|
| 1972 |
Bergmark J, Carlsson A, Granerus AK, Jagenburg R, Magnusson T, Svanborg A. Decarboxylation of orally administered L-dopa in the human digestive tract. Naunyn-Schmiedeberg's Archives of Pharmacology. 272: 437-40. PMID 4260263 DOI: 10.1007/BF00501249 |
0.508 |
|
| 1972 |
Bédard P, Carlsson A, Lindqvist M. Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain Naunyn-Schmiedebergs Archives of Pharmacology. 272: 1-15. PMID 4257469 DOI: 10.1007/Bf00498790 |
0.335 |
|
| 1970 |
Andén NE, Carlsson A, Kerstell J, Magnusson T, Olsson R, Roos BE, Steen B, Steg G, Svanborg A, Thieme G, Werdinius B. Oral L-dopa treatment of parkinsonism. Acta Medica Scandinavica. 187: 247-55. PMID 4911257 DOI: 10.1111/J.0954-6820.1970.Tb02939.X |
0.548 |
|
| 1969 |
Carlsson A, Jonason J, Lindqvist M. On the mechanism of 5-hydroxytryptamine release by thymoleptics. Journal of Pharmacy and Pharmacology. 21: 769-773. PMID 4390836 DOI: 10.1111/J.2042-7158.1969.Tb08167.X |
0.313 |
|
| 1968 |
Carlsson A, Meisch J, Waldeck B. On the β-hydroxylation of (±)-α-methyldopamine in vivo European Journal of Pharmacology. 5: 85-92. PMID 5718522 DOI: 10.1016/0014-2999(68)90160-X |
0.327 |
|
| 1968 |
Carlsson A, Lindqvist M, Waldeck B. Mechanism of release of α-methylated noradrenaline analogues by monoamine oxidase inhibitors European Journal of Pharmacology. 3: 34-39. PMID 5654667 DOI: 10.1016/0014-2999(68)90045-9 |
0.324 |
|
| 1967 |
Carlsson A, Lindqvist M. Metatyrosine as a tool for selective protection of catecholamine stores against reserpine European Journal of Pharmacology. 2: 187-192. PMID 5590341 DOI: 10.1016/0014-2999(67)90085-4 |
0.406 |
|
| 1967 |
Carlsson A, Fuxe K, Hökfelt T. Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate. Journal of Pharmacy and Pharmacology. 19: 481-483. PMID 4382644 DOI: 10.1111/J.2042-7158.1967.Tb08116.X |
0.343 |
|
| 1965 |
ANDEN NE, CARLSSON A, HILLARP NA, MAGNUSSON T. NORADRENALINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD. Life Sciences. 4: 129-32. PMID 14283073 |
0.447 |
|
| 1965 |
Trčka V, Carlsson A. Mediodespidine, hypotensive reserpoid without sedative effect II. Effect on monoamine levels in mouse organs Life Sciences. 4: 2263-2267. PMID 5880876 DOI: 10.1016/0024-3205(65)90247-X |
0.386 |
|
| 1964 |
ANDEN NE, CARLSSON A, HILLARP NA, MAGNUSSON T. 5-HYDROXYTRYPTAMINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD. Life Sciences. 3: 473-8. PMID 14198489 |
0.442 |
|
| 1964 |
SEIDEN LS, CARLSSON A. BRAIN AND HEART CATECHOLAMINE LEVELS AFTER L-DOPA ADMINISTRATION IN RESERPINE TREATED MICE: CORRELATIONS WITH A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 5: 178-81. PMID 14138753 DOI: 10.1007/BF00413240 |
0.498 |
|
| 1963 |
Andén N, Carlsson A, Waldeck B. Reserpine-Resistent Uptake Mechanisms Of Noradrenaline In Tissues. Life Sciences. 2: 889-894. PMID 14100218 DOI: 10.1016/0024-3205(63)90056-0 |
0.301 |
|
| 1963 |
CARLSSON A, MAGNUSSON T, ROSENGREN E. 5-HYDROXYTRYPTAMINE OF THE SPINAL CORD NORMALLY AND AFTER TRANSECTION. Experientia. 19: 359. PMID 14067768 DOI: 10.1007/BF02152316 |
0.589 |
|
| 1963 |
SEIDEN LS, CARLSSON A. TEMPORARY AND PARTIAL ANTAGONISM BY L-DOPA OF RESERPINE-INDUCED SUPPRESSION OF A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 4: 418-23. PMID 14048562 DOI: 10.1007/BF00403346 |
0.49 |
|
| 1962 |
Carlsson A, Lindqvist M. In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl Metatyrosine Acta Physiologica Scandinavica. 54: 87-94. PMID 13876658 DOI: 10.1111/J.1748-1716.1962.Tb02331.X |
0.36 |
|
| 1962 |
CARLSSON A, HILLARP NA. Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine. Acta Physiologica Scandinavica. 55: 95-100. PMID 13876655 DOI: 10.1111/j.1748-1716.1962.tb02422.x |
0.343 |
|
| 1959 |
BERTLER A, CARLSSON A, ROSENGREN E. Fluorimetric method for differential estimation of the 3-O-methylated derivatives of adrenaline and noradrenaline (metanephrine and normetanephrine. Clinica Chimica Acta; International Journal of Clinical Chemistry. 4: 456-7. PMID 13663254 DOI: 10.1016/0009-8981(59)90120-2 |
0.675 |
|
| 1958 |
BERTLER A, CARLSSON A, ROSENGREN E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiologica Scandinavica. 44: 273-92. PMID 13617023 DOI: 10.1111/j.1748-1716.1958.tb01627.x |
0.686 |
|
| 1958 |
BERTLER A, CARLSSON A, LINDQVIST M, MAGNUSSON T. On the catehol amine in blood plasma after stimulation of the sympathoadrenal system. Experientia. 14: 184-5. PMID 13548132 DOI: 10.1007/Bf02158656 |
0.712 |
|
| 1958 |
CARLSSON A, LINDQVIST M, MAGNUSSON T, WALDECK B. On the presence of 3-hydroxytyramine in brain. Science (New York, N.Y.). 127: 471. PMID 13529006 DOI: 10.1126/Science.127.3296.471 |
0.523 |
|
| 1958 |
Bertler Å, Carlsson A, Lindqvist M, Magnusson T. On the catechol amine levels in blood plasma after stimulation of the sympathoadrenal system Experientia. 14: 232. DOI: 10.1007/BF02159107 |
0.443 |
|
| 1957 |
CARLSSON A, LINDQVIST M, MAGNUSSON T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 180: 1200. PMID 13483658 DOI: 10.1038/1801200A0 |
0.601 |
|
| 1957 |
SHORE PA, PLETSCHER A, TOMICH EG, CARLSSON A, KUNTZMAN R, BRODIE BB. Role of brain serotonin in reserpine action. Annals of the New York Academy of Sciences. 66: 609-15; discussion, . PMID 13425244 DOI: 10.1111/J.1749-6632.1957.Tb40751.X |
0.456 |
|
| 1957 |
Carlsson A, Lindqvist M, Magnusson T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists [16] Nature. 180: 1200. DOI: 10.1038/1801200a0 |
0.57 |
|
| 1956 |
Bertler �, Carlsson A, Rosengren E. Release by reserpine of catechol amines from rabbits' hearts Die Naturwissenschaften. 43: 521-521. DOI: 10.1007/BF00596980 |
0.473 |
|
| 1955 |
CARLSSON A, MAGNUSSON T. Failure to demonstrate antipyretic and analgesic properties of salicylamides. Acta Pharmacologica Et Toxicologica. 11: 248-53. PMID 13301772 DOI: 10.1111/J.1600-0773.1955.Tb00224.X |
0.471 |
|
| 1954 |
Carlsson A, Lindqvist M, Magnusson T. The influence of vitamin D on the uptake of S35-labelled sulfate in the bones. Acta Physiologica Scandinavica. 31: 312-316. PMID 13197103 DOI: 10.1111/J.1748-1716.1954.Tb01143.X |
0.479 |
|
| Show low-probability matches. |
